Bioprosthetic aortic valve replacement in <50 years old patients - where is the evidence?
Rev. bras. cir. cardiovasc
;
34(6): 729-738, Nov.-Dec. 2019. tab
Artículo
en Inglés
| LILACS
| ID: biblio-1057506
ABSTRACT
Abstract Aortic valve disease is one of the most common valvular heart diseases in the cardiovascular category. Surgical replacement of the diseased aortic valve remains the definitive intervention for most diseases. There is a clear consensus that in young patients who require aortic valve replacement, a mechanical prosthesis is the preferred choice due to its durable prosthesis without fear of wear and tear over time. However, this comes at the expense of increased risk of bleeding and thromboembolic events; in addition, there is a lack of strict evidence in using bioprosthesis in patients younger than 50 years. The objective of this review article is to assess the current evidence behind using bioprosthetic aortic valve in this young cohort.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Válvula Aórtica
/
Bioprótesis
/
Prótesis Valvulares Cardíacas
/
Implantación de Prótesis de Válvulas Cardíacas
/
Enfermedades de las Válvulas Cardíacas
Tipo de estudio:
Estudio de etiología
/
Factores de riesgo
Límite:
Humanos
Idioma:
Inglés
Revista:
Rev. bras. cir. cardiovasc
Asunto de la revista:
Cardiología
/
Cirugía General
Año:
2019
Tipo del documento:
Artículo
País de afiliación:
China
/
Reino Unido
Institución/País de afiliación:
Liverpool Heart and Chest Hospital/GB
/
Manchester Royal Infirmary/GB
/
The Chinese University of Hong Kong/CN
Similares
MEDLINE
...
LILACS
LIS